23rd International Congress on Thromboses of the Mediterranean League Against Thromboembolic Diseases (What is novel for an obstetrician/gynecologist?)

Mel'nikov A.P.; Koval' A.A.

doi:https://doi.org/10.17116/rosakush2015156109-113

Mel'nikov A.P.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii

Koval' A.A.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii

23rd International Congress on Thromboses of the Mediterranean League Against Thromboembolic Diseases (What is novel for an obstetrician/gynecologist?)

Authors:

Mel'nikov A.P., Koval' A.A.

More about the authors

Journal: Russian Bulletin of Obstetrician-Gynecologist. 2015;15(6): 109‑113

DOI: 10.17116/rosakush2015156109-113

Read: 506 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Mel'nikov AP, Koval' AA. 23rd International Congress on Thromboses of the Mediterranean League Against Thromboembolic Diseases (What is novel for an obstetrician/gynecologist?). Russian Bulletin of Obstetrician-Gynecologist. 2015;15(6):109‑113. (In Russ.)
https://doi.org/10.17116/rosakush2015156109-113

Подписка 2026 Российский вестник акушера-гинеколога (Russian Bulletin of Obstetrician-Gynecologist)

Использование инфографики авторами научных работ

References:

Braza-Boils A, Salloum-Asfar S, Marí-Alexandre J, Arroyo A, González-Conejero R, Vicente V, Estellés A, Gilabert-Estellés J, Martínez C. Mirnaz 16, 424 and 29C regulate VEGF-A expression in endometrial stromal cells from women with endometriosis. Abstract C0418.
Redondo-Izal A, de Diego I, Rodriguez-Huertas A, Lamas P, Rodriguez-Martorell F, Martinez O, Casellas M, Tássies D, Santamaria A, Ramirez I, Gutierrez-Pimentel MJ. Spanish registry of thromboembolic disease (TD) related with hormonal therapy, pregnancy, obstetrics complications oк assisted reproductive techniques in women (ARP): preliminary results of the team project. Abstract C0155.
Caro M, Lopez S, Socias M, Lupianez I, Moratonas E. Puerperal venous thromboembolic disease. Analysis of thrombotic risk factors and compliance of antithrombotic prophylaxis with low molecular weight heparin. Abstract C0537.
Tabares A, Scagliotti F, Larcher J, Benitez M, Albertini R. Survey of risk factors for venous thromboembolic disease in pregnant women in a tertiary care academic hospital from Cordoba, Argentina. Abstract C0425.
Liante V, Mico L, Escandell A, Mira Y, Ferrando F, Marinez-Sales V. Endothelial dysfunction biomarkersin women with obstetric antiphospholipid syndrome. Abstract C0570.
Ozakpinar O, Sahih S, Verimli N, Eroglu M, Tetik S, Uras F. The growth arrest-specific (Gas6) gene olymorphism C.834+7G>A associated with preeclampsia. Abstract C0555.
Eroglu M, Ozakpinar O, Turkgeldi L, Sahin S, Herkiloglu D, Uras F. The plasma levels of Gas6 in recurrent pregnancy losses. Abstract C0558.
Rachieru A, Panea C, Petrescu S. Cerebral Venous Thrombosis. Risk Factors and Evolution. Abstract C0404.
Prochazka M, Slavik L, Prochazkova J, Ulehlova J, Novak M, Polak P, Pilka R. The role of tissue factor in activation coagulation system at pregnancy complication. Abstract C0322.
Villani M, Chinni E, Colaizzo D, Scianname N, Matteo M, Greco P, Fischetti L, Vergura P, Favuzzi G, Vecchione G, Capucci F, Margaglione M, Grandone E. Modulation of factors involved in placental haemostasis and angiogenesis by low-molecular-weight heparin. Abstract C0393.
Božič-Mijovski M, Kozak M. Anti-Xa levels in pregnant women receiving 5000IU dateparin daily. Abstract C0601.
Makarovska-Bojadzieva T, Todorovska E, Apostolovska R, Nikoloska I, Neceva V, Velkova E, Samonikov-Tosevska J, Blagoevska M. Evaluation of D-dimer levels in pregnant women according to gestational week. Abstract C0145.
Samonikov-Tosevska J, Makarovska-Bojadzieva T, Todorovska E, Nikoloska I, Neceva V, Apostolovska R, Blagoevska M, Velkova E. D-dimer levels and thromboprophylaxis after delivery. Abstract C0205.
Tassies D, Martin L, Martinez-Zamora MA, Garcia E, Monteagudo J, Creus M, Carmona F, Balasch J, Reverter JC. Circulatin procoagulant cell-derived microparticles in women with recurrent miscarriage associated with with the antiphospholipid syndrome. Abstract C0527.
Remotti L, Grusso SH, Ingratti MF, Woods A, Bermejo E, Sanchez-Luceros A, Blamco AN, Vera Morandini MP, Lazzari MA. Lupus anticoagulant in patients without thrombotic or obstetric complications. Abstract С0184.
Cooper P, Hickey K, Maclean R, Kitchen S, Makris M. Pregnancy may falsely reduce antithrombin antigen levels in latex-based assays. Abstract C0327.
Conard J, Belaisch-Allart J, Creusvaux H, Galanaud JP, Lamy C, Laporte S, Larue L, Merlet F, Mottier D, Pariente-Khayat A, Plu-Bureau G. Guidelines for the prevention of arterial and venous thrombosis during assisted reproductive technologies. Abstract C0575.
Villani M, Tiscia G, Colaizzo D, Petruccelli T, Fusilli S, Sciannamè N, Petruzzelli F, Greco P, Margaglione M, Grandone E. Pregnancy related venous thromboembolism: comparison between spontaneous and ART conception. Abstract C0390.
Capote Lopez S, Casellas Caro M, Carbonell Socias M, Hurtado Lupiznez I. Epidemiology of acute episode of thrombosis in patients submitted to assisted reproduction techniques. Abstract C0533.
Reverter JC, Garcia E, Martinez-Zamora MA, Martin L, Casals G, Monteagudo J, Civico S, Carmona F, Balasch J, Tassies D. Increased circulating procoagulant microparticles are associated with recurrent implantation failure after in vitro fertilization and embryo transfer. Abstract C0514.
Mathieu d’Argent E, Van Dreden P, Comtet M, Gkalea V, Ketatni H, Antoine J-M, Bouffard S, Rousseau A, Lefcou E, Elalamy I, Gerotziafas G. Impact of thrombin generation, tissue factor activity and thrombomodulin activity on the positivity of assisted reproductive technique in infertile women. Abstract C0531.
Popoutsi A, Koutsounida M., Pehlivanis A, Pantelios A, Antou N, Papgrigoriou M, Kioumourtzi G. Prevalence of polymorphism in the ACE and PAI-1 genes in healthy population of northern Greece. Abstract C0506.
Ivanov P, Komsa-Penkova R, Konova E, Ivanov V, Gecheva S, Kovacheva K, Simeonova S. Plasminogen activator inhibitor type 1 activity: impaired fibrinolysis and early pregnancy wastage. Abstract C0543.
Bhakuni T, Sharma A, Mahapatra M, Saxena R, Aman Jairajpuri M. Assessment of various thrombophilic risk factors and RS2227589 in Indian RPL population. Abstract C0161.
Pruner I, Djordjevic V, Gvozdenov M, Tomic B, Kovac M, Miljic P, Radojkovic D. The C20068T gene variant in the 3 end of the prothrombin gene is the risk factor for recurrent pregnancy lost. Abstract C0300.
Kovac M, Mikovic Z, Mandic V, Djordjevic V, Radojkovia D, Lalic-Cosic S, Elezovic I. A high prophylactic LMWH dose successfully suppressed haemostatic activity in pregnant woman with a new prothrombin FII G20031T (C.1787G>A) mutation. Abstract C0218.